Your browser doesn't support javascript.
loading
The 2021-2022 position of Brazilian Diabetes Society on insulin therapy in type 1 diabetes: an evidence-based guideline to clinical practice.
Silva Júnior, Wellington S; Gabbay, Monica Andrade Lima; Lamounier, Rodrigo Nunes; Calliari, Luis Eduardo; Bertoluci, Marcello Casaccia.
Affiliation
  • Silva Júnior WS; Brazilian Diabetes Society (Sociedade Brasileira de Diabetes-SBD), São Paulo, Brazil. wellington.santana@ufma.br.
  • Gabbay MAL; Endocrinology Discipline, Department of Medicine I, Faculty of Medicine, Center of Biological Sciences, Federal University of Maranhão (UFMA), Praça Gonçalves Dias, 21, Centro, São Luís, MA, 65020-240, Brazil. wellington.santana@ufma.br.
  • Lamounier RN; Brazilian Diabetes Society (Sociedade Brasileira de Diabetes-SBD), São Paulo, Brazil.
  • Calliari LE; Federal University of São Paulo (Unifesp), São Paulo, SP, Brazil.
  • Bertoluci MC; Brazilian Diabetes Society (Sociedade Brasileira de Diabetes-SBD), São Paulo, Brazil.
Diabetol Metab Syndr ; 14(1): 189, 2022 Dec 12.
Article in En | MEDLINE | ID: mdl-36510287

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Guideline / Observational_studies Country/Region as subject: America do sul / Brasil Language: En Journal: Diabetol Metab Syndr Year: 2022 Document type: Article Affiliation country: Brasil

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Guideline / Observational_studies Country/Region as subject: America do sul / Brasil Language: En Journal: Diabetol Metab Syndr Year: 2022 Document type: Article Affiliation country: Brasil